EGFR and cancer: An alternative glycolytic pathway utilizing the M2 isoform of pyruvate kinase [50], [51] and identification of SGLT1 in EGFR expressing cancer cells [10] are recent discoveries in the field of cancer cell glucose metabolism which deviate from the dogmatic, textbook representation of glycolysis and suggest there is much still to learn about cancer cell metabolism.